Literature DB >> 26114316

The sweet side of YAP/TAZ.

Giulia Santinon1, Elena Enzo, Sirio Dupont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26114316      PMCID： PMC4614080          DOI： 10.1080/15384101.2015.1062328

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.

Authors:  Sophia Y Lunt; Matthew G Vander Heiden
Journal:  Annu Rev Cell Dev Biol       Date:  2011       Impact factor: 13.827

2.  Metabolic control of YAP and TAZ by the mevalonate pathway.

Authors:  Giovanni Sorrentino; Naomi Ruggeri; Valeria Specchia; Michelangelo Cordenonsi; Miguel Mano; Sirio Dupont; Andrea Manfrin; Eleonora Ingallina; Roberta Sommaggio; Silvano Piazza; Antonio Rosato; Stefano Piccolo; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2014-03-23       Impact factor: 28.824

3.  Energy stress tames the Hippo pathway.

Authors:  Iswar K Hariharan
Journal:  Nat Cell Biol       Date:  2015-04       Impact factor: 28.824

Review 4.  A two-way street: reciprocal regulation of metabolism and signalling.

Authors:  Kathryn E Wellen; Craig B Thompson
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-07       Impact factor: 94.444

5.  Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.

Authors:  Zhongyuan Wang; Yanping Wu; Haifeng Wang; Yangqing Zhang; Lin Mei; Xuexun Fang; Xudong Zhang; Fang Zhang; Hongbo Chen; Ying Liu; Yuyang Jiang; Shengnan Sun; Yi Zheng; Na Li; Laiqiang Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

Review 6.  The biology of YAP/TAZ: hippo signaling and beyond.

Authors:  Stefano Piccolo; Sirio Dupont; Michelangelo Cordenonsi
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312
  6 in total
  4 in total

1.  Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells.

Authors:  Tian-Yi Zhou; Lin-Han Zhuang; Yan Hu; Yu-Lu Zhou; Wen-Kai Lin; Dan-Dan Wang; Zi-Qian Wan; Lin-Lin Chang; Ying Chen; Mei-Dan Ying; Zi-Bo Chen; Song Ye; Jian-Shu Lou; Qiao-Jun He; Hong Zhu; Bo Yang
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

2.  The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma.

Authors:  Shengchen Lin; Chongbiao Huang; Jianwei Sun; Oana Bollt; Xiuchao Wang; Eric Martine; Jiaxin Kang; Matthew D Taylor; Bin Fang; Pankaj K Singh; John Koomen; Jihui Hao; Shengyu Yang
Journal:  EMBO Mol Med       Date:  2019-10-21       Impact factor: 12.137

Review 3.  The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.

Authors:  Ángel Ortega; Ivana Vera; Maria P Diaz; Carla Navarro; Milagros Rojas; Wheeler Torres; Heliana Parra; Juan Salazar; Juan B De Sanctis; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

4.  YAP1 nuclear efflux and transcriptional reprograming follow membrane diminution upon VSV-G-induced cell fusion.

Authors:  Daniel Feliciano; Carolyn M Ott; Isabel Espinosa-Medina; Aubrey V Weigel; Lorena Benedetti; Kristin M Milano; Zhonghua Tang; Tzumin Lee; Harvey J Kliman; Seth M Guller; Jennifer Lippincott-Schwartz
Journal:  Nat Commun       Date:  2021-07-23       Impact factor: 14.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.